SUSupport expands to bring in Indian partner

By Ben Hargreaves contact

- Last updated on GMT

(Image: Getty/Mputsylo)
(Image: Getty/Mputsylo)

Related tags: Single Use Support, India, Supply chain, Single-use systems

The Austrian startup provides its single-use equipment to PharmNXT in India.

Single Use Support is based in Tyrolean, Austria, and is specialized in providing single-use equipment to the biopharma industry.

The startup aims to supply equipment to ‘close the gap’ between downstream processing and the fill & finish process.

According to the company, the aim is to provide a secure logistics process for single-use bags, which includes fully automated filling and freezing, refrigerated transport, thawing and emptying of the drugs.

PharmNXT, based in Mumbai, has developed a collaboration with SUSupport to acquire its product portfolio, which it will add to its own capabilities to provide end-to-end equipment for the production of biologics.

According to co-founder of SUSupport, Johannes Kirchmair, the Bulk.Stream process allows for a reduced risk of product loss, as the ‘complete solution’ minimizes the potential for bio-contamination.

As part of this process, up to 20 bags can be filled in parallel to achieve a total volume of up to 200L, with a ‘Freeze-Thaw’ platform allowing the product to be frozen, after which the product can then be transported with SUSupport’s containers.

According to the startup, the expansion into the Indian market follows on from also receiving orders for its products in Europe, the US and China.

Related news

Show more

Related products

The Reagents Behind Much of Molecular Biology

The Reagents Behind Much of Molecular Biology

Thermo Fisher Scientific | 25-Jul-2022 | Case Study

The ability to amplify, modify and fabricate DNA is fundamental to modern molecular biology. Why do so many researchers take their constituent parts for...

Fill-Finish Biologics

Fill-Finish Biologics

Curia | 16-May-2022 | Technical / White Paper

The clinical value of biologics for the treatment of many disease indications has been accompanied by phenomenal sales. By 2026, the global market for...

Related suppliers

Follow us


View more